Actualités Theracryf Plc - TCF | Actions London Stock Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

*TheraCryf calls March 7 GM for shareholders to approve equity raise

...

*TheraCryf says fresh equity to be used to complete pre-clinical development of Ox-1

...

*TheraCryf raises GBP4.3m from placing, subscription of 1.70b new shares at 0.25p

...

Theracryf PLC £4.25m Placing and Subscription, Notice of GM

Theracryf PLC 19 February 2025 THIS ANNOUNCEMENT, INCLUDING THE APPENDIX, AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND NOT FOR...

Theracryf PLC Appointment of Dr Alastair Smith as Chair

Theracryf PLC 19 February 2025 TheraCryf plc ("TheraCryf", the "Company" or the "Group") Experienced life sciences executive, Dr Alastair...

TheraCryf narrows loss, advances drug programmes after acquisition

TheraCryf PLC said on Thusday its half-year pretax loss narrowed as it advanced drug development programmes in oncolo ...

Theracryf PLC Half-year Report

Theracryf PLC 28 November 2024 TheraCryf plc ("TheraCryf" or "the Company" or "the Group") Half Year Report to 30 September 2024 ...

TheraCryf gets European patent for drug acquired from new subsidiary

TheraCryf PLC on Wednesday confirmed it had been awarded a Composition of Matter patent in Europe for a new drug trea ...

Theracryf PLC Holding(s) in Company

Theracryf PLC 15 November 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BSVYN304 Issuer Name...

Theracryf PLC Issue of Equity and Total Voting Rights

Theracryf PLC 14 November 2024 TheraCryf plc ("TheraCryf", the "Company" or the "Group") Issue of Equity and Total Voting Rights Alderley...

Theracryf PLC Notice of Results

Theracryf PLC 14 November 2024 TheraCryf plc ("TheraCryf", the "Company" or the "Group") Notice of Interim results and Presentation via...

EXECUTIVE CHANGES: Sanderson hires in UK and US; Oberon gets Penny

The following is a round-up of London-listed company director and manager changes announced on Friday and Monday and ...

Theracryf PLC Passing of Dr Sue Foden, Chair

Theracryf PLC 04 November 2024 TheraCryf plc ("TheraCryf", the "Company" or the "Group") Passing of Dr Sue Foden, Chair Alderley Park, UK...

Theracryf PLC Grant of Options and PDMR Dealings

Theracryf PLC 29 August 2024 TheraCryf plc ("TheraCryf", the "Company" or the "Group") Grant of Options, Surrender of Existing Options and...

Theracryf PLC Holding(s) in Company

Theracryf PLC 08 August 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BSVYN304 Issuer Name THERACRYF...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Theracryf Plc (TCF)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

TCF Actualités

*TheraCryf calls March 7 GM for shareholders to approve equity raise

*TheraCryf says fresh equity to be used to complete pre-clinical development of Ox-1

*TheraCryf raises GBP4.3m from placing, subscription of 1.70b new shares at 0.25p

Theracryf PLC £4.25m Placing and Subscription, Notice of GM

Theracryf PLC Appointment of Dr Alastair Smith as Chair

TheraCryf narrows loss, advances drug programmes after acquisition

Theracryf PLC Half-year Report

TheraCryf gets European patent for drug acquired from new subsidiary

Theracryf PLC Holding(s) in Company

Theracryf PLC Issue of Equity and Total Voting Rights

Theracryf PLC Notice of Results

EXECUTIVE CHANGES: Sanderson hires in UK and US; Oberon gets Penny

Theracryf PLC Passing of Dr Sue Foden, Chair

Theracryf PLC Grant of Options and PDMR Dealings

Theracryf PLC Holding(s) in Company

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Theracryf Plc (TCF) Actualités

Theracryf Plc (TCF)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

TCF Actualités

*TheraCryf calls March 7 GM for shareholders to approve equity raise

*TheraCryf says fresh equity to be used to complete pre-clinical development of Ox-1

*TheraCryf raises GBP4.3m from placing, subscription of 1.70b new shares at 0.25p

Theracryf PLC £4.25m Placing and Subscription, Notice of GM

Theracryf PLC Appointment of Dr Alastair Smith as Chair

TheraCryf narrows loss, advances drug programmes after acquisition

Theracryf PLC Half-year Report

TheraCryf gets European patent for drug acquired from new subsidiary

Theracryf PLC Holding(s) in Company

Theracryf PLC Issue of Equity and Total Voting Rights

Theracryf PLC Notice of Results

EXECUTIVE CHANGES: Sanderson hires in UK and US; Oberon gets Penny

Theracryf PLC Passing of Dr Sue Foden, Chair

Theracryf PLC Grant of Options and PDMR Dealings

Theracryf PLC Holding(s) in Company

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités